Bnp Paribas Asset Management Holding S.A. Bio N Tech Se Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Bio N Tech Se stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 4,559 shares of BNTX stock, worth $458,817. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,559
Previous 9,782
53.39%
Holding current value
$458,817
Previous $1.16 Million
55.34%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BNTX
# of Institutions
365Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$827 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$444 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$432 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$191 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$182 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...